Hercules Capital
Venture debt for innovators
San Mateo, CA, United States
Hercules Capital is a specialty finance company that provides senior secured venture growth loans (venture debt) to high-growth technology and life sciences companies. Founded in 2003 and publicly traded since 2005, it has committed over $25 billion to more than 700 companies, offering non-dilutive financing solutions from $10 million to $200 million.
How We Help
Problem Statement
High-growth, venture capital-backed companies, particularly in life sciences and healthcare, often require significant capital for development and expansion but may wish to avoid further equity dilution. Hercules Capital solves this by providing non-dilutive, senior secured venture growth loans.
Core Technology
Venture lending and financial expertise (note: not a technology company in the traditional sense)
Key Differentiators
Offers non-dilutive financing solutions, provides customizable and less dilutive financing to support long-term success, and complements existing equity capital.
Clinical Focus
Life sciences and healthcare, including biotechnology, pharmaceuticals, medical devices, diagnostics, healthcare services, and healthcare technology.
Target Customers
High-growth, innovative, venture capital-backed companies, especially within the life sciences and healthcare industries.
Company Info
- Business Model
- Other
- Founded
- 2003
- Total Funding
- 2,630,000,000
- Website
- herculescapital.com
Categories
Disease Areas
Technologies
Clinical & IP
Clinical Validation
Portfolio includes FDA-regulated diagnostics, medical devices, therapeutics, and healthcare delivery companies at clinical validation stages.
MedStartr Index Score
?What do you think of Hercules Capital?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.